Sort
141,003 grants matching “cytokine”
Transcriptional Regulation of Immune Cell Development, Activation and Functions
$893,775Jinfang Zhu · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Role of ASIC3 in the Etiology of Fibromyalgia
$893,569Kathleen A Sluka · University Of Iowa · R01 · FY2009 · AR
MULTIPURPOSE ARTHRITIS &MUSCULOSKELETAL DISEASES CENTER
$893,240University Of North Carolina Chapel Hill · P60 · FY2001 · AR
Mediators of fatty liver disease during HIV/SIV and cART treatment
$893,138Donald L Sodora · Seattle Children'S Hospital · R01 · FY2019 · AI
Project 2 - Ex Vivo Analysis of Coronavirus Tropism, Adaptation, Replication, and Host Response
$893,131Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2025 · AI
Central Nervous System Drug Delivery Techniques
$893,116Russell Lonser · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
Signal and Transcription Factor Network interactions in Head and Neck Cancer
$893,066Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2010 · DC
Hallmarks of Protective Immunity in Sequential Rhinovirus Infections in Humans
$892,938Judith A Woodfolk · University Of Virginia · U01 · FY2017 · AI
Study of CAR T cells and mechanisms of resistance in pediatric brain tumors
$892,774Anandani Nellan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Multiplexed screening of protein expression libraries
$892,747Lawrence Michael Kauvar · Experimed Bioscence, Inc. · R44 · FY2007 · GM
The effect of cytomegalovirus, inflammation, and immune activation on neurodevelopment in children exposed to maternal HIV infection
$892,566Jennifer Ann Slyker · University Of Washington · P01 · FY2022 · HD
Palliative care intervention for socioeconomically disadvantaged cancer patients
$892,431Jennifer L. Steel · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Neurodifferentiation/Stem Cell Unit
$892,381David Wang · National Institute Of Neurological Disorders And Stroke · ZIC · FY2022 · NS
Development of novel immunotherapy for influenza virus infection
$892,349Kazue Takahashi · Massachusetts General Hospital · U01 · FY2008 · AI
Combined cytokine therapy for sustained HIV remission
$892,227Vijayakumar Velu · Emory University · R01 · FY2024 · AI
A Novel Immunological Probiotic for Treating Inflammatory Bowel Disease
$892,209Gary Fanger · Rise Therapeutics, Llc · R44 · FY2020 · DK
Role of Regulatory T Cells in Parasitic Infections
$892,072Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Genetic &Clinical Risk for Human SLE Nephritis
$892,060Ohio State University · P01 · FY2001 · DK
Innate Determinants of Microbial Immunity
$892,059Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
TNF-receptors and programmed cell death in regulation of autoimmunity
$892,002Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2016 · AR
Combined cytokine therapy for sustained HIV remission
$891,856Vijayakumar Velu · Emory University · R01 · FY2020 · AI
Immune Control of Group B Streptococcal Placental
$891,718Lakshmi Rajagopal · Seattle Children'S Hospital · R01 · FY2020 · AI
Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation
$891,525Stuart C Sweet · Washington University · U01 · FY2008 · AI
Molecular signatures for liver cancer diagnosis and treatment stratification
$891,493Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Therapeutic targets and novel anticancer agents for endocrine cancers
$891,488Naris Nilubol · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA